T 0401/22 of 01.10.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T040122.20241001
- Date of decision
- 1 October 2024
- Case number
- T 0401/22
- Online on
- 13 November 2024
- Petition for review of
- -
- Application number
- 14162934.5
- IPC class
- A61M 15/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Dispensing device
- Applicant name
- Pfizer Limited
- Opponent name
- Glaxo Group Limited
- Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal 2020 Art 015(3)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 123(2)
- Keywords
- Novelty - (no)
Amendments - added subject-matter (yes)
Inventive step - auxiliary request (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 1157/24
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.